SWITCIP-500

CIPROFLOXACIN TABLETS USP 500 MG

Ciprofloxacin is a broad-spectrum anti-infective agent of the fluoroquinolone class. Ciprofloxacin has in vitro activity against a wide range of gram-negative and gram-positive microorganisms. The chemical name for Ciprofloxacin Hydrochloride is 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride, the molecular formula is C17H18FN3O3, HCl and molecular weight is 367.8. The Chemical Structure is:

COMPOSITION

INDICATIONS

SWITCIP 500 tablets are indicated for the treatment of the following infections.
Lower respiratory tract infections due to Gram-negative bacteria
Exacerbations of chronic obstructive pulmonary disease
Broncho-pulmonary infections in cystic fibrosis or in bronchiectasis
Pneumonia
Chronic suppurative otitis media
Acute exacerbation of chronic sinusitis especially if these are caused by Gram-negative bacteria
Urinary tract infections
Genital tract infections
Gonococcal uretritis and cervicitis due to susceptible Neisseria gonorrhoeae
Epididymo-orchitis including cases due to susceptible Neisseria gonorrhoeae
Pelvic inflammatory disease including cases due to susceptible Neisseria gonorrhoeae
Infections of the gastro-intestinal tract (e.g. travellers’ diarrhoea)
Intra-abdominal infections
Infections of the skin and soft tissue caused by Gram-negative bacteria
Malignant external otitis
Infections of the bones and joints
Prophylaxis of invasive infections due to Neisseria meningitidis
Inhalation anthrax (post-exposure prophylaxis and curative treatment)
Ciprofloxacin may be used in the management of neutropenic patients with fever that is suspected to be due to a bacterial infection.
Broncho-pulmonary infections in cystic fibrosis caused by Pseudomonas aeruginosa
Complicated urinary tract infections and pyelonephritis
Inhalation anthrax (post-exposure prophylaxis and curative treatment)
STORAGE : Store in a cool dry place below 25°C, protect from light.
PRESENTATION : 1×10 Tablets in one monopack.